Compounds are disclosed relating to the treatment of cancer that include tocotrienols and derivatives of tocotrienols including 2,5,7,8-tetramethyl-2- ((3E,7E)-4,8,12-trimethyltrideca-3,7,l l-trienyl)chroman-6- ylphenylsulfonylcarbamate; (R)-2,8-dimethyl-2-((3E,7E)-4,8,12-trimethyltrideca- 3,7,1 l-trienyl)chroman-6-yl tosylcarbamate; and (R)-2,5,7,8-tetramethyl-2- ((3E,7E)-4,8, 12-trimethyltrideca-3,7, 1 l-trienyl)chroman-6-yl benzylcarbamate. Therapeutic uses of these types of compounds are also taught.
披露了涉及癌症治疗的化合物,包括
生育三烯酚及其衍
生物,包括2,5,7,8-四甲基-2-((3E,7E)-4,8,12-三甲基十三碳烯-3,7,11-
三烯基)色苷-6-基苯磺酰
氨基甲酸酯;(R)-2,8-二甲基-2-((3E,7E)-4,8,12-三甲基十三碳烯-3,7,11-
三烯基)色苷-6-基对
甲苯磺酰
氨基甲酸酯;以及(R)-2,5,7,8-四甲基-2-((3E,7E)-4,8,12-三甲基十三碳烯-3,7,11-
三烯基)色苷-6-基苄基
氨基甲酸酯。这些类型化合物的治疗用途也得到了教导。